PDF file: 441-1280_myocarditis_anti_COVID_19_injections_administered_to_each_member_of_the_Canadian.pdf
OPQ ID: 441-1280
Session: 441
Question number: Q-1280
Sessional paper: Q-1280
Title: myocarditis, anti-COVID-19 injections, administered to each member of the Canadian Armed Forces (CAF);
Short description: 
Topic: vaccines
Identified concern: 
Keywords: 
Agencies: HC, DND
Date asked: 2023-02-15
Date tabled: 
Submitted by: Mrs. Gallant (Renfrew-Nipissing-Pembroke)
Reply by: Minister of National Defence Réponse de la ministre de la Défense nationale Bryan May PRINT NAME OF SIGNATORY INSCRIRE LE NOM DU SIGNATAIRE SIGNATURE MINISTER OR PARLIAMENTARY SECRETARY MINISTRE OU SECRÉTAIRE PARLEMENTAIRE
Responded by: Minister of National Defence Réponse de la ministre de la Défense nationale Bryan May PRINT NAME OF SIGNATORY INSCRIRE LE NOM DU SIGNATAIRE SIGNATURE MINISTER OR PARLIAMENTARY SECRETARY MINISTRE OU SECRÉTAIRE PARLEMENTAIRE
Pages: 7
Status: not processed
Alert: yellow
Questions asked: 4
Questions answered: 4
Percent responded: 100%
Referenced sources: Canada.ca
Referenced links: (none extracted)
Official link: https://www.google.com/search?q=Q-1280+ourcommons.ca
PDF URL: https://ivim.ca/foi/opq/r/441-1280_myocarditis_anti_COVID_19_injections_administered_to_each_member_of_the_Canadian.pdf
TXT URL: https://ivim.ca/foi/opq/r/441-1280.txt
Original filename: Q-1280, myocarditis, anti-COVID-19 injections, administered to each member of the Canadian Armed Forces (CAF);.pdf
Local source path: C:\Users\Dmitry\Documents\CODES\OPQ-App\data-raw\OPQ\ALL OPQ TO DATE\2022\Q-1280, myocarditis, anti-COVID-19 injections, administered to each member of the Canadian Armed Forces (CAF);.pdf
Machine extracted at: 2026-06-30 12:58:13

References / links:
- Canada.ca

Machine notes:
(none)

Question text preview:
With regard to the Department of National Defence, and in reference to vaccine doses sorted by brand listed on the government's response to Order Paper question Q-1069: (a) what was the number of each type of injection, including anti-COVID-19 injections, administered to each member of the Canadian Armed Forces (CAF);
(b) what was number of myocarditis cases that were reported after receiving the anti-COVlD-19 injections;
(c) what are the details, including the numbers, of all non-serious and serious adverse events after receiving anti-COVID-19 injections; and (d) for each non-serious and serious event listed in (c), what is the breakdown by age of the CAF members?